Overall, these data suggest that deferoxamine treatment attenuated pressure-induced retinal degeneration by inhibiting endogenous increase of Lcn2, but not by inhibiting retinal uptake of extracellular Lcn2. This evidence concerns the gene LCN2 and retinal degeneration.